cellular
• smaller, with shorter and more sparse membrane strands, in resting and LPS+IL4 activated B cells
|
• reduced viability and increased apoptosis of CD3+ splenic T cells after stimulation with OVA or anti-CD3 + anti-CD28
|
• smaller ER, with shorter and more sparse membrane strands, in resting and LPS+IL4 activated B cells
|
hematopoietic system
• reduced viability and increased apoptosis of CD3+ splenic T cells after stimulation with OVA or anti-CD3 + anti-CD28
|
• mislocalization of HSPA5 chaperone protein from ER to Golgi in resting B cells
• mislocalization of CALR and ERP29 chaperone proteins from ER to Golgi in LPS+IL4 activated B cells
• reduced IgG secretion after LPS+IL4 stimulation
|
• reduced B cell IgG secretion after LPS+IL4 stimulation
|
immune system
N |
• normal cellularity and B cell development in bone marrow
• normal cellularity in thymus, spleen and lymph nodes
• normal thymocyte development
• normal splenic B cell subsets and marginal zone B cells
• normal CD4+ and CD8+ T cell distribution in spleen and inguinal and mesenteric lymph nodes
• normal spleen histology
• no autoantibodies in serum
• no T cell lymphopenia
• normal B cell proliferation and viability after LPS+IL4 stimulation
• normal plasmablast differentiation after LPS+IL4 stimulation of B cells
• normal class switching recombination after LPS+IL4 stimulation of B cells
• normal serum IgA and IgM levels
• normal germinal center (GC) size after TNP-KLH immunization
• normal T follicular helper cell germinal center (GC) B cell percentages after TNP-KLH immunization
• normal proliferation and activation of CD3+ splenic T cells after stimulation with anti-CD3 + anti-CD28
• normal T cell toxicity against allogeneic targets and normal NK cell cytotoxicity
|
• reduced viability and increased apoptosis of CD3+ splenic T cells after stimulation with OVA or anti-CD3 + anti-CD28
|
• mislocalization of HSPA5 chaperone protein from ER to Golgi in resting B cells
• mislocalization of CALR and ERP29 chaperone proteins from ER to Golgi in LPS+IL4 activated B cells
• reduced IgG secretion after LPS+IL4 stimulation
|
• reduced B cell IgG secretion after LPS+IL4 stimulation
|
• reduced splenic T cell IFNG secretion after stimulation with OVA or anti-CD3 + anti-CD28
owing to reduced number of cells
• normal per cell splenic T cell IFNG secretion after stimulation with anti-CD3 + anti-CD28
|
• mean body weight 70% of weight before cohousing with pet store mice at cohousing day 22
• hunched posture and ruffled fur after cohousing 22 days with pet store mice
• increased serum IFNA and IFNG levels after cohousing 11 or 22 days with pet store mice
• increased serum IL6 levels after cohousing 22 days with pet store mice
• decreased numbers of CD3+, CD4+, CD8+ and B220+ cells in spleen after cohousing 22 days with pet store mice
• increased percentage of CD69+ and CD44+ cells after cohousing 22 days with pet store mice
• reduced T cell proliferation after anti-CD3 + anti-CD28 exposure after cohousing 22 days with pet store mice
• increased B220-lo CD138+ plasmablast numbers in spleen after cohousing 22 days with pet store mice
• after cohousing 22 days with pet store mice
• normal increase in serum IgG levels after cohousing 22 days with pet store mice
• normal B cell proliferation following LPS+IL4 stimulation after cohousing 22 days with pet store mice
|
homeostasis/metabolism
N |
• normal insulin, glucose, alanine aminotransferase (ALT) and alkaline phosphatase (ALP) levels in serum
|
• reduced splenic T cell IFNG secretion after stimulation with OVA or anti-CD3 + anti-CD28
owing to reduced number of cells
• normal per cell splenic T cell IFNG secretion after stimulation with anti-CD3 + anti-CD28
|
mortality/aging
• mean body weight 70% of weight before cohousing with pet store mice at cohousing day 22
• hunched posture and ruffled fur after cohousing 22 days with pet store mice
• increased serum IFNA and IFNG levels after cohousing 11 or 22 days with pet store mice
• increased serum IL6 levels after cohousing 22 days with pet store mice
• decreased numbers of CD3+, CD4+, CD8+ and B220+ cells in spleen after cohousing 22 days with pet store mice
• increased percentage of CD69+ and CD44+ cells after cohousing 22 days with pet store mice
• reduced T cell proliferation after anti-CD3 + anti-CD28 exposure after cohousing 22 days with pet store mice
• increased B220-lo CD138+ plasmablast numbers in spleen after cohousing 22 days with pet store mice
• after cohousing 22 days with pet store mice
• normal increase in serum IgG levels after cohousing 22 days with pet store mice
• normal B cell proliferation following LPS+IL4 stimulation after cohousing 22 days with pet store mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
combined immunodeficiency | DOID:0111962 | J:345528 | ||
polyclonal hypergammaglobulinemia | DOID:2344 | J:345528 |